Back to Archived Journals » Comparative Effectiveness Research » Volume 8

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China [Corrigendum]

Total article views   HTML views PDF downloads Totals
5,335 Dovepress* 5,335+ 654 5,989
Totals 5,335 654 5,989
*Since 24 January 2018

View citations on Google Scholar